Permissive Hypotension in Hemorrhagic Shock: Evidence and Clinical Application

Conceptual Foundation

Traditional trauma resuscitation dogma held that aggressive early fluid administration to normalize blood pressure was beneficial in hemorrhagic shock. The landmark 1994 Bickell trial in penetrating torso trauma fundamentally challenged this premise, demonstrating worse outcomes in patients receiving immediate prehospital fluid resuscitation compared with those in whom fluids were withheld until surgical hemorrhage control.

This observation gave rise to the concept of permissive hypotension—the deliberate acceptance of a below-normal blood pressure during active hemorrhage to reduce the rate of ongoing blood loss, avoid dilutional coagulopathy, and prevent disruption of early clot formation, while supporting minimally adequate perfusion to vital organs.

Rationale

Aggressive fluid resuscitation in the context of uncontrolled hemorrhage creates a physiologic paradox. Each increment of volume given:

1. Elevates systemic pressure, mechanically disrupting nascent clot at injury sites and increasing the hydrostatic pressure driving blood loss
2. Dilutes clotting factors and platelets, impairing the coagulation cascade at precisely the moment it is most needed
3. Induces hypothermia, as large volumes of room-temperature crystalloid lower core temperature and worsen coagulopathy
4. Acidifies the patient, particularly when large volumes of 0.9% NaCl are used, further impairing enzymatic coagulation function

The combination of hypothermia, acidosis, and coagulopathy—the "lethal triad" of trauma—is partially iatrogenic when aggressive normalization of blood pressure is pursued before surgical hemorrhage control.

Target Thresholds in Dogs

The goal of permissive hypotension is to provide the minimum perfusion pressure compatible with conscious mentation, myocardial function, and renal viability without triggering the adverse effects described above.

Recommended targets during active hemorrhage prior to definitive control:

• Mean arterial pressure (MAP): 50–60 mmHg
• Systolic blood pressure: 80–90 mmHg
• Evidence of adequate end-organ perfusion: mentation, urine output ≥ 1 mL/kg/hr (once achievable), responsive pupils

Small aliquot crystalloid boluses (5–10 mL/kg) should be used to achieve and maintain these targets rather than large-volume resuscitation. Hypertonic saline (7.2–7.5%) may be considered as a volume-sparing alternative in patients with head injury where even transient hypotension must be minimized.

Damage Control Resuscitation

Permissive hypotension is one component of a broader damage control resuscitation (DCR) philosophy that emphasizes early balanced blood product administration in patients with massive hemorrhage. Where feasible, a 1:1 ratio of packed red blood cells to fresh frozen plasma provides volume replacement while simultaneously replenishing clotting factors lost through hemorrhage and dilution.

Tranexamic acid (TXA), an antifibrinolytic agent with a well-established survival benefit in human trauma, is increasingly used in veterinary trauma medicine. Current empirical dosing in dogs is 10–20 mg/kg IV, administered within 3 hours of injury. Evidence in veterinary species remains limited but the pharmacologic rationale is sound.

Contraindications and Limitations

Permissive hypotension is contraindicated in:

• Traumatic brain injury (TBI): even brief hypotension significantly worsens secondary brain injury. Target MAP ≥ 80 mmHg in confirmed or suspected TBI.
• Spinal cord injury: perfusion pressure to the injured cord must be maintained
• Pre-existing severe anemia: reduced oxygen-carrying reserve narrows the safety margin for hypotension

Cats have a narrower hemodynamic reserve than dogs and are less tolerant of sustained hypotension. Targets should be adjusted upward (MAP ≥ 55–65 mmHg) and duration of permissive hypotension minimized in feline patients.

Transition to Definitive Care

Permissive hypotension is a bridge strategy, not a destination. It is appropriate only for the interval between initial patient contact and definitive hemorrhage control. Once the bleeding source is controlled—surgically or through interventional techniques—resuscitation targets shift to normalization of blood pressure, correction of coagulopathy, and restoration of oxygen-carrying capacity.

Prolonged permissive hypotension beyond the period of active hemorrhage causes unnecessary end-organ ischemia and worsens outcomes. Clear communication between the emergency and surgical teams regarding the patient's hemodynamic trajectory is essential to ensure timely transition.